Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Net Debt / (EBITDA-CAPEX)

Alexion Pharm Inc Net Debt / (EBITDA-CAPEX) Chart (ALXN)

Alexion Pharm Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Alexion Pharm Inc Net Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $0m a 84.38% increase of 0m year over year
  • Alexion Pharm Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $0m a 85.75% increase of 0m year over year
  • Alexion Pharm Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a -2,812.44% decrease of -1m from 2018
  • Alexion Pharm Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $1m a -74.45% decrease of -1m from 2017
  • Alexion Pharm Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $2m a -49.28% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN Net Debt / (EBITDA-CAPEX) Data

09/2020$0m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m

Annual ALXN Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$1m
2017$2m
2016$2m
2015$4m
2014$-2m
2013$-2m
2012$-2m
2011$-2m
2010$-2m